Norris Medicines Ltd — Insider Trading, 26-12-2025: Insider Trading / SAST

Norris Medicines Limited has announced the closure of its trading window for Designated Persons, including Promoters, Directors, and Key Managerial Personnel. This window will be closed starting January 1, 2026, and will reopen 48 hours after the company declares its unaudited financial results for the quarter ending December 31, 2025. This measure is in place to prevent insider trading ahead of the upcoming financial disclosure. The company will announce the date of the board meeting to approve these financial results at a later time.